These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9881501)

  • 1. Changes in plasma and colonic mucosa fatty acid profiles in rats with ulcerative colitis induced by trinitrobenzene sulfonic acid.
    Nieto N; Giron MD; Suarez MD; Gil A
    Dig Dis Sci; 1998 Dec; 43(12):2688-95. PubMed ID: 9881501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid.
    Nieto N; Fernandez MI; Torres MI; Ríos A; Suarez MD; Gil A
    Dig Dis Sci; 1998 Dec; 43(12):2676-87. PubMed ID: 9881500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis.
    Nieto N; Torres MI; Ríos A; Gil A
    J Nutr; 2002 Jan; 132(1):11-9. PubMed ID: 11773501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
    D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
    FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.
    Pearl DS; Masoodi M; Eiden M; Brümmer J; Gullick D; McKeever TM; Whittaker MA; Nitch-Smith H; Brown JF; Shute JK; Mills G; Calder PC; Trebble TM
    J Crohns Colitis; 2014 Jan; 8(1):70-9. PubMed ID: 23619007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.
    Miklavcic JJ; Hart TD; Lees GM; Shoemaker GK; Schnabl KL; Larsen BM; Bathe OF; Thomson AB; Mazurak VC; Clandinin MT
    World J Gastroenterol; 2015 Sep; 21(35):10080-90. PubMed ID: 26401073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation.
    Fernández-Bañares F; Esteve-Comas M; Mañé J; Navarro E; Bertrán X; Cabré E; Bartolí R; Boix J; Pastor C; Gassull MA
    Clin Nutr; 1997 Aug; 16(4):177-83. PubMed ID: 16844596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary manipulation in experimental inflammatory bowel disease.
    Guarner F; Vilaseca J; Malagelada JR
    Agents Actions; 1992; Spec No():C10-4. PubMed ID: 1442325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.
    Nishida T; Miwa H; Shigematsu A; Yamamoto M; Iida M; Fujishima M
    Gut; 1987 Aug; 28(8):1002-7. PubMed ID: 3117625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine.
    Nieto N; Torres MI; Fernández MI; Girón MD; Ríos A; Suárez MD; Gil A
    Dig Dis Sci; 2000 Sep; 45(9):1820-7. PubMed ID: 11052326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal and colonic fatty acid profiles in patients with active Crohn's disease.
    Bühner S; Nagel E; Körber J; Vogelsang H; Linn T; Pichlmayr R
    Gut; 1994 Oct; 35(10):1424-8. PubMed ID: 7959199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating TNBS-induced colitis in rats with probiotics.
    Wan YM; Zhu YQ; Xia B; Luo J
    Turk J Gastroenterol; 2011 Oct; 22(5):486-93. PubMed ID: 22234755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats.
    Maheshwari RA; Balaraman R; Sailor GU; Sen DB
    Indian J Pharmacol; 2015; 47(1):17-21. PubMed ID: 25821305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary resistant starch alters the characteristics of colonic mucosa and exerts a protective effect on trinitrobenzene sulfonic acid-induced colitis in rats.
    Morita T; Tanabe H; Sugiyama K; Kasaoka S; Kiriyama S
    Biosci Biotechnol Biochem; 2004 Oct; 68(10):2155-64. PubMed ID: 15502362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats.
    Tyagi A; Kumar U; Santosh VS; Reddy S; Mohammed SB; Ibrahim A
    Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):289-97. PubMed ID: 25451558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
    Sarkate A; Dhaneshwar SS
    World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
    Takagi T; Naito Y; Okuda T; Uchiyama K; Adachi S; Mizushima K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation.
    Allgayer H; Deschryver K; Stenson WF
    Gastroenterology; 1989 May; 96(5 Pt 1):1290-300. PubMed ID: 2539306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Da Silva S; Keita ÅV; Mohlin S; Påhlman S; Theodorou V; Påhlman I; Mattson JP; Söderholm JD
    Inflamm Bowel Dis; 2018 Mar; 24(4):792-805. PubMed ID: 29529198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.